Orders are usually processed within 1–4 working days and shipped Monday–Friday.

PT-141 10mg Vial

PT-141 10mg Vial

[contact-form][contact-field label=”Name” type=”name” required=”true” /][contact-field label=”Email” type=”email” required=”true” /][contact-field label=”Website” type=”url” /][contact-field label=”Message” type=”textarea” /][/contact-form]

25 £

In Stock

Product Specifications

6 in stock

Overview:

PT-141, also known as bremelanotide, is a synthetic peptide derived from α-melanocyte-stimulating hormone (α-MSH).

It acts primarily on melanocortin receptors in the central nervous system.

Mechanism of Action:

Agonist at melanocortin receptors (primarily MC3R and MC4R)
Modulates central nervous system pathways involved in sexual arousal
Acts independently of the nitric oxide pathway (unlike PDE5 inhibitors)

Research & Clinical Context:

Studied for hypoactive sexual desire disorder (HSDD)
Investigated in both male and female sexual dysfunction
Evaluated for effects on appetite and energy balance via melanocortin signaling

Regulatory Status:

Bremelanotide (brand name Vyleesi) is FDA-approved in the United States for

premenopausal women with HSDD under specific medical supervision.

However, compounded or research-use versions are not equivalent to approved

pharmaceutical products.

Safety Considerations:

Reported side effects in clinical trials include nausea, flushing, headache, and

transient increases in blood pressure.

FOR RESEARCH USE ONLY

Reviews

No reviews yet.

Add a review

Related Research Products

Browse similar research peptides available for controlled laboratory applications.

Semax Amidate 30mg Vial

80 £

Epithalon 50mg Vial

60 £

MOTS-C 40mg Vial

100 £

NAD+ 1000mg Vial

100 £

Tesamorelin 10mg Vial

45 £

Ipamorelin 10mg Vial

45 £

Semax 10mg Vial

30 £

AOD 9604 5mg Vial

45 £

Related Research Products

Browse similar research peptides available for controlled laboratory applications.